Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact
Crossref DOI link: https://doi.org/10.1007/s00280-016-3199-z
Published Online: 2016-11-22
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Murakami, Yoshiaki
Uemura, Kenichiro
Sudo, Takeshi
Hashimoto, Yasushi
Kondo, Naru
Nakagawa, Naoya
Takahashi, Shinya
Sueda, Taijiro
License valid from 2016-11-22